Immuneering Corp. (IMRX)
5.26
-0.06
(-1.13%)
USD |
NASDAQ |
Mar 26, 15:01
Immuneering Free Cash Flow : -45.49M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Vanda Pharmaceuticals, Inc. | -110.44M |
| Verastem, Inc. | -147.13M |
| Phathom Pharmaceuticals, Inc. | -167.00M |
| Tango Therapeutics, Inc. | -139.93M |
| X4 Pharmaceuticals, Inc. | -88.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -9.841M |
| Cash from Investing (Quarterly) | -88.72M |
| Cash from Financing (Quarterly) | -0.3575M |
| Free Cash Flow Per Share (Quarterly) | -0.1543 |
| Free Cash Flow to Equity (Quarterly) | -9.873M |
| Free Cash Flow to Firm (Quarterly) | -9.964M |
| Free Cash Flow Yield | -19.68% |